• ورود به سامانه
      مشاهده مورد 
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Asian Pacific Journal of Cancer Prevention
      • Volume 20, Issue 3
      • مشاهده مورد
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Asian Pacific Journal of Cancer Prevention
      • Volume 20, Issue 3
      • مشاهده مورد
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      The Nudix Hydrolase 15 (NUDT15) Gene Variants among Jordanian Arab Population

      (ندگان)پدیدآور
      Jarrar, Yazun BashirGhishan, Maria
      Thumbnail
      دریافت مدرک مشاهده
      FullText
      اندازه فایل: 
      467.5کیلوبایت
      نوع فايل (MIME): 
      PDF
      نوع مدرک
      Text
      Research Articles
      زبان مدرک
      English
      نمایش کامل رکورد
      چکیده
      Background: Nudix Hydrolase 15 gene (NUDT15) encodes nucleotide triphosphate diphosphatase which metabolizesthe purine analog drugs, such as anticancer thiopurine and anti-gout allopurinol. Genetic variants on Nudix Hydrolase15 gene (NUDT15) gene effects the drug's hydrolyses and hence increases the susceptibility to drug-induced toxicity.The NUDT15 gene has been genotyped in various ethnic groups, however, it has not been genotyped among theMiddle Eastern Arab Jordanian population. Aim: The current study aimed to identify NUDT15 genetic variants amongJordanian Arab population. Method: The DNA samples were isolated from leukocytes of 85 unrelated JordanianArab volunteers. The coding regions of NUDT15 gene; Exon 1,2 and 3, in addition to some regions of intron 1,2 and3'UTR, were amplified using polymerase chain reaction (PCR). the PCR products were then subjected to purificationand sequenced using Applied Biosystems Model (ABI3730x1). Results: Six NUDT15 genetic variants were foundamong the volunteers.The results were as followed: A novel synonymous variant 36A>G on exon 1 (6%, 95%CI=G on exon 1 (6%, 95%CI=3- 9%), the intronic IVS1 +116C>T variant on intron 1 (0.6%, 95%CI= 0-2%), the non-synonymous variant on exonT variant on intron 1 (0.6%, 95%CI= 0-2%), the non-synonymous variant on exon3; 415C>T (0.6%, 95%CI= 0-2%), A novel non-synonymous variant on exon 3; 404C>A (0.6%, 95%CI= 0-2%) , andT (0.6%, 95%CI= 0-2%), A novel non-synonymous variant on exon 3; 404C>A (0.6%, 95%CI= 0-2%) , andA (0.6%, 95%CI= 0-2%) , andtwo novel variants on 3'UTR ;502G>A (2%, 95%CI= 0.5-4%) and 588T>C (0.6%, 95%CI= 0-2%). NUDT15 36A>GA (2%, 95%CI= 0.5-4%) and 588T>C (0.6%, 95%CI= 0-2%). NUDT15 36A>GC (0.6%, 95%CI= 0-2%). NUDT15 36A>GGwasfound to be the most common allele among Jordanians was. In silico softwares predicted that the novel NUDT15404C>A was harmful and affected NUDT15 enzyme'sstability and function. Furthermore, the frequency of NUDT15A was harmful and affected NUDT15 enzyme'sstability and function. Furthermore, the frequency of NUDT15IVS1 +116C>T , among Jordanians, showed to be significantly lower from what was reported in other ethnicities withT , among Jordanians, showed to be significantly lower from what was reported in other ethnicities withap value > 0.05 on the other hand, the frequency of 415C>T variant showed to be similar to Europeans in contrast to 0.05 on the other hand, the frequency of 415C>T variant showed to be similar to Europeans in contrast toT variant showed to be similar to Europeans in contrast toAsians and Indians that showed to be significantly lower (p value > 0.05). Conclusions: The frequency of NUDT15 0.05). Conclusions: The frequency of NUDT15genetic variants is low among the Jordanian volunteers and significantly lower than other ethnic groups. The findings ofthis study may increase our understanding of the inter-individual variation in the response to purine analog drugs. Furtherclinical studies are needed to investigate the influence of novel NUDT15 404C>A on drug metabolism and response.
      کلید واژگان
      NUDT15
      Jordanians
      genetic variants
      Metabolism
      Pharmacogenetics

      شماره نشریه
      3
      تاریخ نشر
      2019-03-01
      1397-12-10
      ناشر
      West Asia Organization for Cancer Prevention (WAOCP)
      سازمان پدید آورنده
      College of Pharmacy, AlZaytoonah University of Jordan, Amman, Jordan.
      College of Pharmacy, AlZaytoonah University of Jordan, Amman, Jordan.

      شاپا
      1513-7368
      2476-762X
      URI
      https://dx.doi.org/10.31557/APJCP.2019.20.3.801
      http://journal.waocp.org/article_82661.html
      https://iranjournals.nlai.ir/handle/123456789/32203

      مرور

      همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

      حساب من

      ورود به سامانهثبت نام

      تازه ترین ها

      تازه ترین مدارک
      © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
      تماس با ما | ارسال بازخورد
      قدرت یافته توسطسیناوب